Skip to main content
SpringerLink
Log in

External Beam Radiotherapy

  • Chapter
Thyroid Cancer

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamietz IA, Schiemann MS, Petkauskas JG, Schemmann F, Bottcher HD (1998) Prognostic factors and the effect of radiotherapy in the treatment of differentiated thyroid carcinomas. Strahlenther Onkol 174:618–623

    PubMed  Google Scholar 

  2. Bal C, Padhy AK, Jana S, Pant GS, Basu AK (1996) Prospective randomised clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma. Cancer 77:2574–2580

    Article  PubMed  Google Scholar 

  3. Belin RM, Ladenson PW, Robinson KA, Powe NR (2002) Development and use of evidence-based clinical practice guidelines for thyroid disease. Endocrinol Metab Clin North Am 31:795–817

    Article  PubMed  Google Scholar 

  4. Biermann M, Nofer JR, Riemann B, Lu J, Wilde J, Schober O (2004) Clinical evaluation of a new highly sensitive thyroglobulin assay (Nichols Advantage) in 99 patients with differentiated thyroid cancer (DTC) after total thyroidectomy (abstract). Clin Chem 50: A73

    Article  Google Scholar 

  5. Biermann M, Pixberg MK, Schober O (2003) Changing patterns of care for locally advanced differentiated thyroid carcinoma (DTC) in German-speaking Europe since 1996 (abstract). Eur J Nucl Med 30:S155

    Google Scholar 

  6. Biermann M, Pixberg MK, Schuck A, Heinecke A, Köpcke W, Schmid KW, Dralle H, Willich N, Schober O, for the MSDS study group (2003) Multicenter Study Differentiated Thyroid Carcinoma (MSDS): diminished acceptance of adjuvant external beam radiotherapy for differentiated thyroid carcinoma. Nuklearmedizin 42:244–250

    PubMed  Google Scholar 

  7. Biermann M, Schober O (2002) GCP-compliant management of the Multicentric Study Differentiated Thyroid Carcinoma (MSDS) with a relational database under Oracle 8i. Inform Biom Epidemiol Med Biol 33:441–459

    Google Scholar 

  8. Biermann M, Schober O (2003) Should High hTG levels in absence of iodine uptake be treated? Eur J Nucl Med 30:160–163

    Article  Google Scholar 

  9. Biermann M, Schober O (2002) How many high-risk patients with differentiated thyroid carcinoma does a “tumor center” need per year? (Editorial) Nuklearmedizin 41:61–62

    PubMed  Google Scholar 

  10. Brearley MJ, Hayes AM, Murphy S (1999) Hypofractionated radiation therapy for invasive thyroid carcinoma in dogs: a retrospective analysis of survival. J Small Anim Pract 40:206–210

    PubMed  Google Scholar 

  11. Brierley JD, Tsang RW (1999) External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol 16:42–49

    Article  PubMed  Google Scholar 

  12. Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, Busnardo B (1993) Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626–1631

    PubMed  Google Scholar 

  13. Chebotareva ED, Shishkina VV, Siniuta BF, Dzhuzha DA, Cheren'ko SM, Sheptukha AI, Gorobeiko MB, Ivanov NA (2002) Analysis of efficacy of complex treatment of patients with differentiated forms of the thyroid gland cancer using distant radiation therapy. Klin Khir pp 25–28

    Google Scholar 

  14. Chow SM, Law SC, Mendenhall WM, Au SK, Chan PT, Leung TW, Tong CC, Wong IS, Lau WH (2002) Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys 52:784–795

    Article  PubMed  Google Scholar 

  15. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH (2002) Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 95:488–498

    Article  PubMed  Google Scholar 

  16. Chung CT, Sagerman RH, Ryoo MC, King GA, Yu WS, Dalai PS, Emmanuel IG (1980) External irradiation for malignant thyroid tumors. Radiology 136:753–756

    PubMed  Google Scholar 

  17. Deutsche Krebsgesellschaft (2002) Malignant thyroid tumors. In: Concise interdisciplinary guidelines 2002. Zuckschwerdt, Germering

    Google Scholar 

  18. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    PubMed  Google Scholar 

  19. Eichhorn W, Tabler H, Lippold R, Lochmann M, Schreckenberger M, Bartenstein P (2003) Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid 13:949–958

    PubMed  Google Scholar 

  20. Esik O, Nemeth G, Eller J (1994) Prophylactic external irradiation in differentiated thyroid cancer: a retrospective study over a 30-year observational period. Oncology 51:372–379

    PubMed  Google Scholar 

  21. Farahati J, Reiners C, Stuschke M, Muller SP, Stuben G, Sauerwein W, Sack H (1996) Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 77:172–180

    Article  PubMed  Google Scholar 

  22. Foote RL, Brown PD, Garces YI, McIver B, Kasperbauer JL (2003) Is there a role for radiation therapy in the management of Hurthle cell carcinoma? Int J Radiat Oncol Biol Phys 56:1067–1072

    PubMed  Google Scholar 

  23. Ford D, Giridharan S, McConkey C, Hartley A, Brammer C, Watkinson JC, Glaholm J (2003) External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 15:337–341

    Google Scholar 

  24. Gimm O, Rath FW, Dralle H (1998) Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 85:252–254

    Article  PubMed  Google Scholar 

  25. Glanzmann C, Horst W (1979) Treatment and prognosis of follicular and papillary thyroid carcinoma. Strahlentherapie 155:223–229

    PubMed  Google Scholar 

  26. Glanzmann C, Lütolf UM (1992) Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment. Strahlenther Onkol 168:260–269

    PubMed  Google Scholar 

  27. Glanzmann C, Lütolf UM (1992) Papillary and follicular thyroid carcinoma: Long-term follow-up of 339 patients at Zurich University Hospital between 1960 and 1988, and review. Schweiz Rundsch Med 81:457–467

    Google Scholar 

  28. Hare HF (1941) Radiation treatment of carcinoma of the thyroid. Am J Roentgenol 46:451–453

    Google Scholar 

  29. Harmer C, Bidmead M, Shepherd S, Sharpe A, Vini L (1998) Radiotherapy planning techniques for thyroid cancer. Br J Radiol 71:1069–1075

    PubMed  Google Scholar 

  30. Harmer CL (1977) External beam radiotherapy for thyroid cancer. Ann Radiol Paris 20:791–800

    PubMed  Google Scholar 

  31. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL et al (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885

    Article  PubMed  Google Scholar 

  32. Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911

    PubMed  Google Scholar 

  33. Heinze HG, Schmeis E (1976) Malignome der Schilddrüse. Behandlungsergebnisse bei 305 Patienten. Strahlentherapie 152:114

    PubMed  Google Scholar 

  34. Hölzer S, Reiners C, Mann K, Bamberg M, Rothmund M, Dudeck J, Stewart AK, Hundahl SA (2000) Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. Cancer 89:192–201

    Article  PubMed  Google Scholar 

  35. Hölzer S, Steiner D, Bauer R, Reiners C, Farahati J, Hundahl SA, Dudeck J (2000) Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Eur J Nucl Med 27:1465–1472

    PubMed  Google Scholar 

  36. Hundahl SA, Cady B, Cunningham MP, Mazzaferri EL, McKee R, Rosai J, Shah JP, Fremgen AM, Stewart AK, Hölzer S (2000) Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 89:202–217

    Article  PubMed  Google Scholar 

  37. Jacobson F (1954) Treatment of carcinoma of the thyroid. Acta Radiol 41:169–192

    PubMed  Google Scholar 

  38. Jarzab B (2001) Indications for adjuvant therapy of thyroid cancer with radioiodine therapy. Wiad Lek 54[Suppl 1]:254–265

    PubMed  Google Scholar 

  39. Kim S, Wei JP, Braveman JM, Brams DM (2004) Predicting outcome and directing therapy for papillary thyroid carcinoma. Arch Surg 139:390–394

    Article  PubMed  Google Scholar 

  40. Kim TH, Yang DS, Jung KY, Kim CY, Choi MS (2003) Value of external irradiation for locally advanced papillary thyroid cancer. Int J Radiat Oncol Biol Phys 55:1006–1012

    Article  PubMed  Google Scholar 

  41. Kleinert G (1989) Results of external beam radiotherapy for thyroid cancer. Radiobiol Radiother 30:473–480

    Google Scholar 

  42. Kuijpens JL, Hansen B, Hamming JF, Ribot JG, Haak HR, Coebergh JW(1998) Trends in treatment and long-term survival of thyroid cancer in southeastern Netherlands, 1960–1992. Eur J Cancer 34:1235–1241

    Article  PubMed  Google Scholar 

  43. Kumar H, Daykin J, Holder R, Watkinson JC, Sheppard MC, Franklyn JA (2001) An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings. Clin Endocrinol (Oxf) 54:719–723

    Article  Google Scholar 

  44. Lee D, Cosmatos D, Marcial V (1995) Results of an RTOG phase III trial (RTOG 85–27) comparing radiotherapy plus etonidazole with radiotherapy alone for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 32:567–576

    Article  PubMed  Google Scholar 

  45. Leisner B, Degelmann G, Dirr W, Kanitz W, Bull U, Langhammer H, Lissner J, Pabst HW (1982) Therapeutic results of malignant goiter 1960–1980. Significance of percutaneous radiotherapy in well differentiated carcinomas. Dtsch Med Wochenschr 107:1702–1707

    PubMed  Google Scholar 

  46. Lerch H, Schober O, Kuwert T, Saur HB (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067–2075

    PubMed  Google Scholar 

  47. Li WB, Friedland W, Pomplun E, Jacob P, Paretzke HG, Lassmann M, Reiners C (2001) Track structures and dose distributions from decays of (131)I and (125)I in and around water spheres simulating micrometastases of differentiated thyroid cancer. Radiat Res 156:419–429

    PubMed  Google Scholar 

  48. Lin JD, Liou MJ, Chao TC, Weng HF, Ho YS (1999) Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Endocr Relat Cancer 6:109–115

    Article  PubMed  Google Scholar 

  49. Mabille JP (1961) Résultats thérapeutiques des cancers throidiens. Ann Radiol 4:477–491

    PubMed  Google Scholar 

  50. Maxon HR, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD (1992) Radioiodine-131 therapy for well-differentiated thyroid cancer — a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 33:1132–1136

    PubMed  Google Scholar 

  51. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428

    Article  PubMed  Google Scholar 

  52. Mazzaferri EL, Kloos RT (2001) Current approaches to primary therapy for papillary and follicular thyroid cancer. J Endocrinol Metab 86:1447–1463

    Article  Google Scholar 

  53. Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511–518

    Article  PubMed  Google Scholar 

  54. Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 56:171–96

    PubMed  Google Scholar 

  55. Müller-Gärtner H-W, Brzac HT, Rehpenning W (1991) Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 67:1903–1911

    PubMed  Google Scholar 

  56. Nakashima T, Yano G, Nomura Y, Tomita K, Wada S, Hata K (1994) Use of a remote controlled radiotherapy afterloading system to manage unresectable, metastatic thyroid cancer in the trachea. Eur Arch Otorhinolaryngol 251[Suppl 1]:S73–S75

    PubMed  Google Scholar 

  57. Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Vini L, Harmer C, Dearnaley DP, Webb S (2001) Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 60:173–180

    Article  PubMed  Google Scholar 

  58. O'Connell ME, RP AH, Harmer CL (1994) Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer 30A:733–739

    Article  PubMed  Google Scholar 

  59. Pack L, Roberts RE, Dawson SD, Dookwah HD (2001) Definitive radiation therapy for infiltrative thyroid carcinoma in dogs. Vet Radiol Ultrasound 42:471–474

    Article  PubMed  Google Scholar 

  60. Pape E (2002) External beam radiotherapy for medullary carcinoma with metastases. In: Feldkamp J, Scherbaum WA (eds) Medullary thyroid cancer. De Gruyter, Berlin, pp 83–63

    Google Scholar 

  61. Pemberton JdJ, Black BM (1939) Malignant lesions of the thyroid gland: review of 774 cases. Surg Gynaecol Obstet 69:417–430

    Google Scholar 

  62. Phlips P, Hanzen C, Andry G, van Houtte P, Fruuling J (1993) Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 19:399–404

    PubMed  Google Scholar 

  63. Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J (1995) Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Endocrinol Metab 80:1488–1492

    Article  Google Scholar 

  64. Pollinger B, Duhmke E (2001) External radiotherapy of thyroid cancer. Onkologie 24:134–138

    Article  PubMed  Google Scholar 

  65. Portmann UV (1941) Experience in the treatment of malignant tumors of the thyroid gland. Am J Roentgenol 46:454–466

    Google Scholar 

  66. Puskás C, Biermann M, Willich N, Schober O (2001) Percutaneous radiation therapy. In: Biersack H-J, Grünwald F (eds) Thyroid cancer. Springer, Berlin Heidelberg New York, pp 121–129

    Google Scholar 

  67. Reiners C (2003) Radioiodtherapie des differenzierten Schilddrüsenkarzinoms. Arzneimitteltherapie 2:39–47

    Google Scholar 

  68. Reinhardt M, Guttenberger R, Slanina J, Frommhold H, Moser E (1995) Indications for external beam radiotherapy in thyroid carcinoma. The Freiburg consensus. Radiologe 35:535–539

    PubMed  Google Scholar 

  69. Rossi RL, Cady B, Silverman M, Wool S, ReMine SG, Hodge MB, Salzman FA (1988) Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy. Arch Surg 123:569–574

    PubMed  Google Scholar 

  70. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG (1992) The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1,599 patients. J Clin Endocrinol Metab 75:714–720

    PubMed  Google Scholar 

  71. Sautter-Bihl ML, Heinze HG (1992) External radiotherapy of differentiated thyroid carcinoma. Dtsch Med Wochenschr 117:665–668

    PubMed  Google Scholar 

  72. Sautter-Bihl ML, Herbold G, Heinze HG, Bihl H (1991) Postoperative external beam radiation in differentiated thyroid cancer: situations in which radioiodine is insufficient? Some dosimetric considerations with Monte Carlo techniques. Strahlenther Onkol 167:267–272

    PubMed  Google Scholar 

  73. Sautter-Bihl M-L, Raub J, Hetzel-Sesterheim M, Heinze HG (2001) Differentiated thyroid cancer: prognostic factors and influence of treatment on the outcome in 441 patients. Strahlenther Onkol 177:125–131

    PubMed  Google Scholar 

  74. Scheumann GFW, Dralle H (1992) External radiotherapy of differentiated thyroid carcinoma (letter). Dtsch Med Wochenschr 117:1576–1577

    PubMed  Google Scholar 

  75. Schlumberger M, Challeton C, de Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases of differentiated thyroid carcinoma. J Nucl Med 37:398–605

    Google Scholar 

  76. Schlumberger M, Pacini F (2003) Thyroid tumors. Éditions Nucléon, Paris

    Google Scholar 

  77. Schuck A, Biermann M, Müller S, Schober O, Willich N (2001) Adjuvant percutaneous radiotherapy in the treatment of differentiated thyroid cancer. Nuklearmediziner 24:225–229

    Google Scholar 

  78. Schuck A, Biermann M, Pixberg MK, Müller S, Schober O, Willich N (2003) Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid cancer: First results of the Multicenter Study Differentiated Thyroid Cancer (MSDS). Strahlenther Onkol 179:821–827

    Article  Google Scholar 

  79. Schümichen C, Schmitt E, Scheuffele C, Blattmann H, Pauli-Harnasch C (1983) Einfluss des Therapiekonzepts auf die Prognose des Schilddrüsenkarzinoms. Nuklearmedizin 23:87–105

    Google Scholar 

  80. Seegenschmidt MH, Sauer R (1993) The systematics of acute and chronic radiation sequelae. Strahlenther Onkol 169:83–95

    PubMed  Google Scholar 

  81. Seegenschmiedt MH, Sautter-Bihl ML, Schmitt G, Willich N, Müller R-P (1998) Guidelines in radiooncology. External beam radiotherapy of malignant struma. AWMF-Guideline registry no. 052/001. http://www.awmf-online.de

    Google Scholar 

  82. Sheline GE, Galante M, Lindsay S (1966) Radiation therapy in the control of persistent thyroid cancer. Am J Roentgenol 97:923–930

    Google Scholar 

  83. Simpson WJ (1990) Radioiodine and radiotherapy in the management of thyroid cancers. Otolaryngol Clin North Am 23:509–521

    PubMed  Google Scholar 

  84. Simpson WJ, Carruthers JS (1978) The role of external radiation in the management of papillary and follicular thyroid cancer. Am J Surg 136:457–460

    Article  PubMed  Google Scholar 

  85. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB (1988) Papillary and follicular thyroid cancer: impact of treatment in 1,578 patients. Int J Radiat Oncol Biol Phys 14:1063–1075

    PubMed  Google Scholar 

  86. Simpson WJ, Sutcliffe SB, Gospodarowicz MK (1994) The thyroid. In: Cox JD (ed) Mossʻ radiation oncology: rationale, technique, results, 7th edn. Mosby International, St. Louis, pp 280–304

    Google Scholar 

  87. Sisson JC, Jamadar DA, Kazerooni EA, Giordano TJ, Carey JE, Spaulding SA (1998) Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine? Thyroid 8:215–21

    PubMed  Google Scholar 

  88. Smedal MI, Salzman FA, Meissner WA (1967) The value of 2 mV roentgen-ray therapy in differentiated thyroid carcinoma. Am J Roentgenol Radium Ther Nucl Med 99:352–364

    PubMed  Google Scholar 

  89. Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL (1998) Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Endocrinol Metab 83:4116–4122

    Article  Google Scholar 

  90. Taylor T, Specker B, Robbins J, Sperling M, Ho M, Ain K, Bigos ST, Brierley J, Cooper D, Haugen B et al (1998) Outcome after treatment of high-risk papillary and non-Hurthlecell follicular thyroid carcinoma. Ann Intern Med 129:622–627

    PubMed  Google Scholar 

  91. Theon AP, Marks SL, Feldman ES, Griffey S (2000) Prognostic factors and patterns of treatment failure in dogs with unresectable differentiated thyroid carcinomas treated with megavoltage irradiation. J Am Vet Med Assoc 216:1775–1779

    PubMed  Google Scholar 

  92. Thomusch O, Dralle H (2000) Endocrine surgery and evidence-based medicine. Chirurg 71:635–645

    Article  PubMed  Google Scholar 

  93. Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB (1998) The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82:375–388

    Article  PubMed  Google Scholar 

  94. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D (1985) External radiotherapy in thyroid cancers. Cancer 55:2062–2071

    PubMed  Google Scholar 

  95. Tubiana M, Tacour J, Monnier J, Bergiron C, Gerard-Marchand R, Roujeau J, Bok B, Parmentier C (1975) External radiotherapy and radioiodine in the treatment of 359 thyroid cancers. Br J Radiol 48:894–907

    PubMed  Google Scholar 

  96. Udelsman R, Lakatos E, Landenson P (1996) Optimal surgery for papillary thyroid carcinoma. World J Surg 20:88–93

    Article  PubMed  Google Scholar 

  97. Windeyer BW (1954) Cancer of the thyroid and radiotherapy. Br J Radiol 27:537–552

    PubMed  Google Scholar 

  98. Wittekind C, Wagner G (1997) TNM classification of malignant tumors. Springer, Berlin Heidelberg New York

    Google Scholar 

  99. Wu XL, Hu YH, Li QH, Guo JR, Sun D, Yan JH, Xu GZ, Qin DX, Ha XW, Gu XZ (1987) Value of postoperative radiotherapy for thyroid cancer. Head Neck Surg 10:107–112

    PubMed  Google Scholar 

  100. Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG (1980) Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med 21:733–737

    PubMed  Google Scholar 

Download references

Authors
  1. M. Biermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.K. Pixberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Schuck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Willich
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Heinecke
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. Schober
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Nuklearmedizin, Rheinische Friedrich-Wilhelms-Universität, Sigmund-Freud-Strasse 25, 53127, Bonn, Germany

    H.-J. Biersack (Professor Dr. med.) (Professor Dr. med.)

  2. Klinik für Nuklearmedizin, Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany

    F. Grünwald (Professor Dr. med.) (Professor Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Biermann, M., Pixberg, M., Schuck, A., Willich, N., Heinecke, A., Schober, O. (2005). External Beam Radiotherapy. In: Biersack, HJ., Grünwald, F. (eds) Thyroid Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27845-1_8

Download citation

  • DOI: https://doi.org/10.1007/3-540-27845-1_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22309-2

  • Online ISBN: 978-3-540-27845-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation